BOSTON (MarketWatch) -- Drug stocks were mixed Wednesday as shares of Wyeth tumbled on news that the FDA will not approve its new antidepressant Pristiq for the treatment of menopausal symptoms unless it conducts another long-term safety study.
From: www.marketwatch.com
Drug stocks mixed; Wyeth falls on FDA setback
Posted by Ruslan Abuzant at 11:56 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment